OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma
Yuhan Chen, Peitao Zhou, Yixun Deng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances
Zuxiang Yu, Chaoyu Xu, Bin Song, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30

RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10

Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue, Runping Liu, Yajie Cai, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
Runping Liu, Yajing Li, Qi Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1009-1029
Open Access | Times Cited: 20

Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7

N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5

Mechanisms of radiation‐induced tissue damage and response
Zhou Lin, Jiaojiao Zhu, Yuhao Liu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 5

N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications
Liming Wang, Yuanxin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114846-114846
Open Access | Times Cited: 13

The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway
Qinyan Yang, Yuxin Liang, Ying Shi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15499-15510
Closed Access | Times Cited: 12

Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10

m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access

Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications
Jianhui Wu, Xiaofang Zhao, Bowen Ren, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1839-1839
Open Access

CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting
Qi Liu, Mingyuan Song, Bin Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189341-189341
Closed Access

Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 8

Clinical significance of RNA methylation in hepatocellular carcinoma
Qiongling Bao, Yifan Zeng, Qizhuo Lou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
J Wang, Wenyue Gao, Hongbo Yu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1143-1156
Open Access | Times Cited: 2

Regulation and application of m6A modification in tumor immunity
Qunli Xiong, Yaguang Zhang, Zheng Ying, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 2

Computational approaches for hematopoietic stem cells
Pawan Kumar Raghav, Basudha Banerjee, Rajesh Kumar, et al.
Elsevier eBooks (2024), pp. 331-346
Closed Access | Times Cited: 1

The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma
Chu‐Li Fu, Zhengwei Zhao, Qiangnu Zhang
Hepatobiliary & pancreatic diseases international (2024)
Closed Access | Times Cited: 1

The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
Ziwei Liao, Jing Wang, Mengrou Xu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

Complicated role of ALKBH5 in gastrointestinal cancer: an updated review
Weitong Shu, Qianying Huang, Rui Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top